Master's in Cancer Research UB 2026: official degree and what it entails

Key data

Graduates who want to specialize in oncological research in Spain now have a new option with an official degree: the Master's Degree in Cancer Research from the University of Barcelona. The Resolution of January 28, 2026 publishes the curriculum of this program in the BOE, fulfilling the legal requirement that grants the degree national validity and European recognition.

Publication in the BOE is not a minor formality: without it, the degree has no official recognition in the European Higher Education Area (EHEA) nor full academic and professional guarantees for those who pursue it. From now on, the UB can teach the program with complete regulatory support.

What does this regulation establish?

The resolution fulfills a specific legal requirement of the Spanish university system: publication in the Official State Gazette of the curriculum of any official degree. Without this step, the master's cannot be considered an official university degree for academic and professional purposes.

The specific points established by the resolution are as follows:

• Official publication of the curriculum of the Master's Degree in Cancer Research from the University of Barcelona.
• Granting of official validity at the national level to the degree.
• Enabling recognition of the degree in the European Higher Education Area (EHEA).
• Authorization for the University of Barcelona to teach the program with complete regulatory support.
• Guarantee of full academic and professional guarantees for future students who obtain the degree.

The master's is oriented toward research training in oncology and is aimed at graduates who wish to specialize in cancer research. It is not a generic professional master's, but rather a program with a research profile within the field of oncology.

Economic and operational impact

This resolution does not generate direct costs for companies nor does it impose economic obligations on third parties. Its impact is academic and institutional in nature. However, it has relevant practical consequences for the affected profiles:

• For master's candidates: they can enroll with the certainty that the degree will have official validity in Spain and throughout the EHEA. Without publication in the BOE, this support would not exist.
• For the University of Barcelona: it is legally enabled to teach the program. Before this publication, the master's could not be offered with official status.
• For employers in the research and healthcare sectors: the degree obtained by graduates of this master's will have official recognition, which facilitates its assessment in selection processes, scholarship calls or access to doctoral programs.
• For oncological research centers: they have a new candidate profile with regulated training and an official degree in cancer research.

There is no published data on tuition fees, number of places or duration in ECTS credits in the resolution analyzed. For that information, it is necessary to consult directly with the University of Barcelona.

Who does it affect?

• University graduates interested in specializing in oncological research.
• Researchers in training seeking an official master's degree in the field of cancer.
• The University of Barcelona, which is enabled to teach the program with full legal support.
• Oncological research centers that incorporate graduates of this master's in their teams.
• Hospitals and healthcare centers with oncology research units that value this degree in their selection processes.
• Research funding organizations (public and private) that require official qualifications for the awarding of scholarships or predoctoral contracts.

Practical example

A graduate in Biology or Medicine who wants to direct their career toward oncological research can enroll in the Master's in Cancer Research at the UB with the certainty that, upon completion, they will obtain a degree with official validity throughout Spain and recognition in the European Higher Education Area.

This has direct consequences: the degree will be valid for accessing doctoral programs at European universities, for competing in predoctoral scholarship calls from organizations such as CSIC or the Carlos III Institute of Health, and for accrediting specialized training to employers in the research and healthcare sectors.

Without the publication of the curriculum in the BOE that this resolution contains, the master's would not have that official recognition and students would not be able to benefit from these guarantees.

What should interested parties do now?

1. If you are a master's candidate: consult directly with the University of Barcelona about the admission schedule, number of places, tuition fees and access requirements. Publication in the BOE confirms the official status of the degree, but operational details are managed by the university itself.
2. If you are responsible for HR or selection at a research center: incorporate this degree into your catalog of recognized qualifications for research profiles in oncology. The degree has official validity as of January 28, 2026.
3. If you manage scholarship or predoctoral contract calls: the Master's in Cancer Research from the UB meets the official qualification requirements to access programs that require a master's degree recognized in the EHEA.
4. If you are an academic manager at another institution: verify whether this program can establish collaboration agreements or joint degrees, given that EHEA recognition opens up that possibility.

Official source

Notice: This article is for informational purposes only and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://www.boe.es/diario_boe/txt.php?id=BOE-A-2026-8942